UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Article
  • Authors:
    Mok MY, Farewell VT, Isenberg DA
  • Publication date:
    06/2000
  • Pagination:
    462, 467
  • Journal:
    Annals of the Rheumatic Diseases
  • Volume:
    59
  • Issue:
    6
  • Print ISSN:
    0003-4967
  • Keywords:
    antibodies, Antibody, bone, factors, necrosis, Patient, patients, Risk, Risk Factors, RISK-FACTORS, Adolescence, adult, age, analysis, antibodies, Antibodies, Anticardiolipin, Antiphospholipid, Anticoagulant, As, Biological Markers, Blood, Case-Control Studies, chosen, coagulation, COAGULATION INHIBITOR, COHORT, complications, control, development, difference, disease, DURATION, Ethnicity, etiology, Female, FOLLOW UP, Follow-up, Follow-Up Studies, groups, IgG, Igm, immunology, INHIBITOR, link, LONG, long term follow up, Lupus Coagulation Inhibitor, Lupus Erythematosus, Systemic, Methods, Middle Age, Osteonecrosis, Other, Prevalence, Rheumatology, Sex, TERM
  • Addresses:
    Bloomsbury Rheumatology Unit, University College London Medical School, Hong Kong. mymok@netvigator.com
  • Notes:
    UI - 20294828 LA - eng RN - 0 (Antibodies, Anticardiolipin) RN - 0 (Antibodies, Antiphospholipid) RN - 0 (Biological Markers) RN - 0 (IgG) RN - 0 (IgM) RN - 0 (Lupus Coagulation Inhibitor) PT - Journal Article DA - 20000706 IS - 0003-4967 SB - IM CY - ENGLAND JC - 62W
Abstract
BACKGROUND: Avascular necrosis of bone (AVN) is a well known complication in patients with systemic lupus erythematosus (SLE). OBJECTIVE: To investigate the role of antiphospholipid antibody status (IgM and IgG anticardiolipin antibodies and lupus anticoagulant) with adjustment for corticosteroid use as risk factors for the development of AVN. METHODS: A cohort of 265 patients receiving long term follow up in our SLE clinic from 1978 to 1998 was analysed. Patients with AVN complications were detected and then matched for age, sex, ethnicity, duration of disease, and organ disease with two other patients with SLE. A further 31 patients were chosen at random for the analysis. RESULTS: Eleven patients had AVN, giving a point prevalence of 4%. There were no significant differences demonstrable in the presence of individual antiphospholipid antibodies (aPL) or their combination between the group with AVN or the two control groups. CONCLUSION: Incorporating an adjustment for corticosteroid use we were unable to show a link between the presence of aPL and the development of AVN in patients with SLE
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by